Clari Vest Asset Management LLC Rhythm Pharmaceuticals, Inc. Transaction History

Clari Vest Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 08, 2023	SELL	$16.88 - $34.24 $36,123 - $73,273	-2,140 Reduced 12.97%	14,360 $256,000
Q4 2022 Feb 14, 2023	SELL	$22.21 - $30.25 $6,663 - $9,075	-300 Reduced 1.79%	16,500 $480,000
Q3 2022 Nov 10, 2022	BUY	$4.3 - $30.85 $72,240 - $518,280	16,800 New	16,800 $412,000
Q2 2020 Aug 12, 2020	SELL	$14.41 - $25.35 $213,268 - $375,180	-14,800 Closed	0 $0
Q1 2020 May 04, 2020	BUY	$13.16 - $22.9 $194,768 - $338,920	14,800 New	14,800 $225,000

189

67.2M

834K

78.6K

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.04B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Clari Vest Asset Management LLC with notifications on news.